Atlas Trials

Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

Clinical trial NCT06735144 · RECRUITING

Trial details

NCT number
NCT06735144
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Solid Tumor
Start date
2024-12-23
Primary completion
2027-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.